Belong.Life, the operator of a cancer-focused online support network, will use the Iqvia-led round to expand its Belong Patient Engagement Platform.
Healthcare data provider Iqvia has led a $14m series B round for Belong.Life, a US-based operator of a digital support network for cancer patients.
The round was filled out by commitments from Group Ventures and undisclosed existing investors.
Founded in 2015, Belong.Life provides an online platform that leverages big data and machine learning technology to help more than 200,00 patients suffering from cancer to manage their treatment.
The company offers a mobile app that allows users to manage documents, access content and communities, as well as connect with professionals such as oncologists, radiologists and researchers that are relevant to particular cancer types.
Belong.Life has allocated the funding to expanding its social network and the Belong Patient Engagement Platform, which provides patients, payers, providers, and life science companies with personalised tools and services.
Tal Rosenberg, senior vice-president of global technology solutions at Iqvia, said: “Our investment in Belong is part of our strategy to identify and accelerate disruptive technologies that can improve healthcare.
“Through its unique patient engagement platform with machine learning and artificial intelligence capabilities, Belong can utilise and complement Iqvia’s solutions to transform patient engagement.”
The company has not confirmed details about previous funding rounds, though VentureBeat reported its total funding now stood at $30m, including a $5m series A round in 2015.